Prognostic significance of CD44 in human colon cancer and gastric cancer: Evidence from bioinformatic analyses

Pu Xia; Xiao-Yan Xu

doi:10.18632/oncotarget.9998

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Prognostic significance of CD44 in human colon cancer and gastric cancer: Evidence from bioinformatic analyses

Pu Xia _ and Xiao-Yan Xu

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2016; 7:45538-45546. https://doi.org/10.18632/oncotarget.9998

Metrics: PDF 3821 views | HTML 2680 views | ?

Abstract

Pu Xia1, Xiao-Yan Xu2

1Department of Cell Biology, College of Basic Medical Science, Liaoning Medical University, Jinzhou, Liaoning, P.R. China

2Department of Pathophysiology, College of Basic Medical Science, China Medical University, Shenyang, Liaoning, P.R. China

Correspondence to:

Pu Xia, email: [email protected]

Keywords: CD44, The Cancer Genome Atlas, gastric cancer, colon cancer, bioinformatic analyses

Received: May 06, 2016 Accepted: May 29, 2016 Published: June 14, 2016

ABSTRACT

CD44 is a well-recognized stem cell biomarker expressed in colon and gastric cancer. In order to identify whether CD44 mRNA could be used as a prognostic marker in colon and gastric cancer, bioinformatic analyses were used in this study. cBioPortal analysis and COSMIC analysis were used to explore the CD44 mutation. CD44 mRNA levels were evaluated by using SAGE Genie tools and Oncomine analysis. Kaplan-Meier Plotter was performed to identify the prognostic roles of CD44 mRNA in these two cancers. In this study, first, we found that low alteration frequency of CD44 mRNA in colon and gastric cancer. Second, the high CD44 mRNA level was found in colon and gastric cancer, and it correlated with a benign survival rate in gastric cancer. Third, CD4 and CD74 may be used as markers to predict the prognosis of colon and gastric cancer. However, the deep mechanism(s) of these results remains unclear, further studies have to be performed in the future.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 9998

Publication Alerts

Research Papers:

Prognostic significance of CD44 in human colon cancer and gastric cancer: Evidence from bioinformatic analyses

Abstract